Mycoplasma Pneumoniae IgG Antibodies

Mycoplasma pneumoniae IgG Antibodies Test

The Mycoplasma pneumoniae IgG Antibodies Test is a laboratory blood test that detects Immunoglobulin G (IgG) antibodies against Mycoplasma pneumoniae, a bacterium that commonly causes atypical pneumonia (walking pneumonia) and other respiratory tract infections. The test helps determine whether a person has had previous exposure to the organism or is in the later stage of a recent infection.

Mycoplasma pneumoniae is one of the smallest bacteria capable of causing disease in humans. Unlike many bacteria, it does not have a cell wall, making it naturally resistant to antibiotics such as penicillins and cephalosporins. Infection spreads through respiratory droplets released when an infected person coughs or sneezes and is common in schools, colleges, military barracks, and households where people are in close contact.

Symptoms usually develop gradually and may include:

• Persistent dry cough
• Fever
• Sore throat
• Fatigue
• Headache
• Chest discomfort
• Mild shortness of breath

Although many infections are mild, some individuals—particularly children, older adults, and people with weakened immune systems—may develop pneumonia or complications such as bronchitis, ear infections, skin rashes, or, rarely, neurological or cardiac involvement.

After infection, the immune system produces IgM antibodies first, followed by IgG antibodies, which usually become detectable 2–4 weeks after infection and may remain present for months or even years. Therefore, a positive IgG result alone does not distinguish between a current infection and a past infection.

The Mycoplasma pneumoniae IgG Test is most useful when interpreted together with IgM antibody testing, paired acute and convalescent serum samples, or PCR testing, particularly in patients with symptoms suggestive of atypical pneumonia. A four-fold rise in IgG antibody levels between paired samples collected 2–4 weeks apart provides stronger evidence of a recent infection than a single positive IgG result.

Benefits of the Test

• Detects IgG antibodies against Mycoplasma pneumoniae.
• Helps identify previous exposure to the organism.
• Supports evaluation of atypical respiratory infections.
• Requires only a simple blood sample.
• Complements IgM antibody and PCR testing.
• Useful in epidemiological investigations.
• Assists clinicians in diagnosis.
• Supports comprehensive respiratory infection assessment.

Why Doctors Recommend This Test

Doctors recommend the Mycoplasma pneumoniae IgG Antibodies Test for patients with persistent cough, suspected atypical pneumonia, prolonged respiratory illness, or when evaluating previous exposure to Mycoplasma pneumoniae.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise. Inform your healthcare provider about your symptoms, recent respiratory infections, antibiotic treatment, travel history, and previous Mycoplasma infections. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 2–5 Working Days

Reporting time may vary depending on the laboratory methodology.

Who Should Take This Test?

This test may be recommended for:

• Individuals with persistent dry cough.
• Patients with suspected atypical pneumonia.
• People with prolonged respiratory symptoms.
• Individuals undergoing evaluation for Mycoplasma infection.
• Patients with unexplained community-acquired pneumonia.
• Children and young adults with respiratory illness.
• Individuals referred by infectious disease or respiratory specialists.
• Patients undergoing paired serology testing.
• Hospitalized patients with atypical pneumonia.
• Anyone advised by their healthcare provider.